Evolent Health Future Growth
Future criteria checks 4/6
Evolent Health is forecast to grow earnings and revenue by 62.2% and 14.1% per annum respectively. EPS is expected to grow by 66.7% per annum. Return on equity is forecast to be 17.1% in 3 years.
Key information
62.2%
Earnings growth rate
66.7%
EPS growth rate
Healthcare Services earnings growth | 28.8% |
Revenue growth rate | 14.1% |
Future return on equity | 17.1% |
Analyst coverage | Good |
Last updated | 25 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 3,303 | 144 | 302 | 320 | 6 |
12/31/2025 | 2,862 | 69 | 240 | 259 | 14 |
12/31/2024 | 2,467 | 20 | 143 | 171 | 14 |
12/31/2023 | 1,964 | -142 | 114 | 143 | N/A |
9/30/2023 | 1,790 | -112 | 55 | 89 | N/A |
6/30/2023 | 1,632 | -77 | -21 | 25 | N/A |
3/31/2023 | 1,483 | -40 | -10 | 38 | N/A |
12/31/2022 | 1,352 | -19 | -59 | -12 | N/A |
9/30/2022 | 1,218 | -4 | -25 | 19 | N/A |
6/30/2022 | 1,088 | -19 | 35 | 67 | N/A |
3/31/2022 | 990 | -24 | 1 | 29 | N/A |
12/31/2021 | 908 | -30 | 11 | 39 | N/A |
9/30/2021 | 906 | -45 | -67 | -41 | N/A |
6/30/2021 | 923 | -68 | -131 | -106 | N/A |
3/31/2021 | 918 | -261 | -74 | -44 | N/A |
12/31/2020 | 925 | -328 | -48 | -16 | N/A |
9/30/2020 | 915 | -515 | -25 | 10 | N/A |
6/30/2020 | 895 | -504 | -26 | 14 | N/A |
3/31/2020 | 870 | -334 | -76 | -37 | N/A |
12/31/2019 | 687 | -304 | -87 | -43 | N/A |
9/30/2019 | 803 | -121 | -126 | -81 | N/A |
6/30/2019 | 733 | -107 | -85 | -42 | N/A |
3/31/2019 | 685 | -86 | -67 | -22 | N/A |
12/31/2018 | 627 | -53 | -190 | -21 | N/A |
9/30/2018 | 548 | -49 | -27 | 10 | N/A |
6/30/2018 | 506 | -49 | -46 | -8 | N/A |
3/31/2018 | 468 | -56 | -54 | -18 | N/A |
12/31/2017 | 435 | -61 | -59 | -28 | N/A |
9/30/2017 | 409 | -65 | N/A | -55 | N/A |
6/30/2017 | 362 | -64 | N/A | -51 | N/A |
3/31/2017 | 311 | -55 | N/A | -49 | N/A |
12/31/2016 | 254 | -160 | N/A | -36 | N/A |
9/30/2016 | 212 | -146 | N/A | -20 | N/A |
6/30/2016 | 192 | -147 | N/A | -35 | N/A |
3/31/2016 | 146 | 220 | N/A | -39 | N/A |
12/31/2015 | 97 | 330 | N/A | -18 | N/A |
9/30/2015 | 51 | 322 | N/A | -12 | N/A |
6/30/2015 | 10 | 329 | N/A | -6 | N/A |
3/31/2015 | N/A | -37 | N/A | 4 | N/A |
12/31/2014 | N/A | -31 | N/A | N/A | N/A |
9/30/2014 | 13 | -29 | N/A | -9 | N/A |
12/31/2013 | 26 | 2 | N/A | -14 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 9EH is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.6%).
Earnings vs Market: 9EH is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 9EH is expected to become profitable in the next 3 years.
Revenue vs Market: 9EH's revenue (14.1% per year) is forecast to grow faster than the German market (5.5% per year).
High Growth Revenue: 9EH's revenue (14.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 9EH's Return on Equity is forecast to be low in 3 years time (17.1%).